event,time
39 years old ,0
female ,0
palpable mass on right breast ,-168
Hodgkin lymphoma ,-6336
chemotherapy ,-6336
mantle field radiation ,-6336
inflammatory colitis ,-6336
mesalazine ,-336
breast cancer ,0
invasive ductal carcinoma ,0
triple-negative phenotype ,0
MIB1 85% ,0
staging CT scan ,0
neoadjuvant chemotherapy ,0
paclitaxel ,0
carboplatin ,0
port-Ã -cath insertion ,48
subcutaneous cellulitis ,96
colliquative necrosis ,96
fever ,96
elevated white blood cell count ,96
neutrophilia ,96
elevated C-reactive protein ,96
broad-spectrum i.v. antibiotic therapy ,96
piperacillin/tazobactam ,96
daptomycin ,96
PORT rimotion ,96
necrosectomy ,96
defervescence ,120
improvement in subcutaneous cellulitis ,120
improvement in blood works ,120
febrile seizure ,144
WBC rise ,144
worsening of skin lesion ,144
second necrosectomy ,144
peripheral blood cultures ,144
skin plug ,144
i.v. catheter tip positivity for Klebsiella pneumoniae ,144
antibiotic therapy modification ,144
meropenem ,144
levofloxacin ,144
chest/abdomen CT scan ,144
mediastinitis ,144
bilateral pleural effusion ,144
left pulmonary atelectasis ,144
thoracoscopy ,144
pleural and mediastinal drainage ,144
sepsis ,144
broad-spectrum antibiotic and antifungal therapy ,144
hemodynamic support ,144
non-invasive ventilation ,144
intensive inflammatory infiltrate ,144
neutrophils ,144
PG diagnosis ,144
systemic methylprednisolone ,144
topical cyclosporine ,144
seriate chest X-ray ,168
progressive resolution of mediastinitis ,168
progressive resolution of pleural effusion ,168
wound improvement ,168
scar ,168
progressive normalization of blood count ,168
progressive normalization of flogosis index ,168
breast ultrasound ,240
no change in the dimension of the lump ,240
multidisciplinary meeting ,240
right mastectomy ,240
axillary dissection ,240
breast surgical wound healing ,240
fibroelastosis ,240
chronic inflammation ,240
isolated neoplastic cells ,240
negative axillary nodes ,240
restaging brain/chest/abdomen CT ,240
negative for distant metastasis ,240
BRCA and p53 mutation tests ,240
negative ,240
autologous skin graft ,432
no further complications ,432
PICC implant ,432
chemotherapy with carboplatin and paclitaxel ,432
dose reduction ,432
good tolerance ,720
follow-up ,720
